Track topics on Twitter Track topics that are important to you
S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization.
The detailed report by a coalition of more than 100 nonprofit groups finds hundreds of patients were affected.
In Florida, perfect timing and alert medical staff saved a teen from almost certain death. But in North Carolina, one young woman died of an amoeba infection after rafting at a popular tourist site.
Highlights of LIVE Day 1: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017 BOSTON, MA • UNITED STATES Leaders in Pharmaceutical Business Intelligence (LPBI) Group will cover...
Pour la première un patient atteint de drépanocytose est en rémission complète suite à traitement par thérapie génique. Cet essai clinique de phase I/I...
Gut bacteria could play a role in the development of diseases like Alzheimer's and Parkinson's.
FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility. read more
First published in 1994, this volume discusses the nature of health care reform and the capacity for medical excellence within the context of such reform.
Human interferon inducible protein 10 (IP-10) is a member of the chemokine family of molecules. It is a secreted protein with a molecular weight of approximately 8.6 kD. Previous work has demonstrated...
IOPE MILD CLINIC SUN PROTECTOR
Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...
Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...
The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans
The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...
Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...
Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...
Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...
Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...
Water Pik is a leading developer, manufacturer and marketer of innovative personal healthcare products sold under the WaterpikÂ® brand name. The Company has developed and introd...
We have published hundreds of S*BIO Pte Ltd news stories on BioPortfolio along with dozens of S*BIO Pte Ltd Clinical Trials and PubMed Articles about S*BIO Pte Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of S*BIO Pte Ltd Companies in our database. You can also find out about relevant S*BIO Pte Ltd Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...